À propos de ce podcast
AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer's, Parkinson’s, and related neurodegenerative diseases. The "AD/PD™ Session Spotlight" series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes. Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the…
18 épisodes · Levenswetenschappen
The AD/PD™ Podcast: Alzheimer’s, Parkinson’s and Neurodegenerative Diseases
À propos de ce podcast
AD/PD™ is the leading international platform dedicated to exploring the latest breakthroughs and treatments in Alzheimer's, Parkinson’s, and related neurodegenerative diseases. The "AD/PD™ Session Spotlight" series is an AI-powered podcast that brings you key insights from the AD/PD™ Conference, with expert presentations and research discussions transformed into concise, easy-to-digest episodes. Join us as we uncover the latest innovations, explore groundbreaking research, and discuss the…
Épisodes récents
- pTau217: Clinical and Economic Benefits to the Healthcare System18 août · 11 min
- Neuropathology in the Biomarker Age & Sleep in Lewy Body Disease, AD/PD™ Session Spotlight6 août · 22 min
- Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Big Pharma, or Academia? AD/PD™ Session Spotlight9 juil. · 23 min
- Drug Development & Biomarkers in Rare CNS Diseases, AD/PD™ Session Spotlight16 janv. · 20 min
- Challenges and Opportunities for Anti-Tau Therapies: Turning Hope Into Clinical Progress, AD/PD™ Session Spotlight14 nov. 2025 · 39 min
- Therapy for AD, PD & LBD: Translational Models, Neuroinflammation, and Novel Therapeutic Targets, AD/PD™ Session Spotlight16 oct. 2025 · 39 min
- Pivotal Points in Prevention Trials and the New Era of Precision Medicine for Alzheimer’s Disease, AD/PD™ Session Spotlight2 oct. 2025 · 18 min
- Novel Approaches to Accelerate Development of Biomarkers, Imaging, and Therapy of Alpha-Synuclein, LRRK2, and GBA Pathologies, AD/PD™ Session Spotlight12 sept. 2025 · 18 min
- Pathogenic Mechanisms of Familial AD and Emerging Therapeutic Developments, AD/PD™ Session Spotlight21 août 2025 · 15 min
- Translational Drug Development in AD: Promising Strategies for Treatment and Disease Modification, AD/PD™ Session Spotlight31 juil. 2025 · 24 min
podlinkr.com/fr/the-ad-pdtm-podcast-alzheimer-s-parkinson-s-and
Pour une affiche ou une diapo.